Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc

Bullboard Posts

Post by GiveMeMoneyon Sep 24, 2020 1:51pm

163 Views

Post# 31612292

Initial trials done soon?

I think they have maybe passed thru their initial trials - there has been some testing on their issue at some test sites in NA. (Unless there's another doing exactly what they are trying to do.)

Problem is, as some have said before, is it a good or bad result?

Spin?

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?